BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schaible J, Stroszczynski C, Beyer L, Jung E, Wiggermann P, Krüger-genge A, Jung F. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization. CH 2019;73:95-104. [DOI: 10.3233/ch-199221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Wei Q, Huang Y, Yao Z, Yan C, Zou X, Han J, Li Q, Mao R, Liao Y, Cao L, Lin M, Zhou X, Tang X, Hu Y, Li L, Wang Y, Yu J, Zhou J. Deep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma. Front Oncol 2022;12:878061. [DOI: 10.3389/fonc.2022.878061] [Reference Citation Analysis]
2 Tufano A, Drudi FM, Angelini F, Polito E, Martino M, Granata A, Di Pierro GB, Kutrolli E, Sampalmieri M, Canale V, Flammia RS, Fresilli D, Bertolotto M, Leonardo C, Franco G, Cantisani V. Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation—Results from a Prospective Single-Center Study. Diagnostics 2022;12:1209. [DOI: 10.3390/diagnostics12051209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dong Y, Koch JBH, Löwe AL, Christen M, Wang WP, Jung EM, Mohaupt MG, Dietrich CF. VueBox® for quantitative analysis of contrast-enhanced ultrasound in liver tumors. Clin Hemorheol Microcirc 2021. [PMID: 34897079 DOI: 10.3233/CH-211261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yi D, Wen-Ping W, Lee WJ, Meloni MF, Clevert DA, Cristina Chammas M, Tannapfel A, Forgione A, Dietrich CF. Hepatocellular carcinoma in the non-cirrhotic liver. Clin Hemorheol Microcirc 2021. [PMID: 34842182 DOI: 10.3233/CH-211309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jiang Y, Zhang M, Zhu Y, Zhu D. Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study. J Gastrointest Oncol 2021;12:2403-11. [PMID: 34790401 DOI: 10.21037/jgo-21-611] [Reference Citation Analysis]
6 Spiesecke P, Fischer T, Maxeiner A, Hamm B, Lerchbaumer MH. Contrast-enhanced ultrasound (CEUS) reliably rules out neoplasm in developmental renal pseudotumor. Acta Radiol 2021;62:821-9. [PMID: 32631079 DOI: 10.1177/0284185120939291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen Y, Wang W. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis. Clin Hemorheol Microcirc 2021. [PMID: 33935070 DOI: 10.3233/CH-211145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Na F, Wang L, Wu C, Ding Y. Contrast‐enhanced ultrasound combined with augmented reality medical technology in the treatment of rabbit liver cancer with high‐energy focused knife. Computational Intelligence 2022;38:121-38. [DOI: 10.1111/coin.12450] [Reference Citation Analysis]
9 McGillen KL, Zaidi S, Ahmed A, Harter S, Yee NS. Contrast-Enhanced Ultrasonography for Screening and Diagnosis of Hepatocellular Carcinoma: A Case Series and Review of the Literature. Medicines (Basel) 2020;7:E51. [PMID: 32867068 DOI: 10.3390/medicines7090051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]